Making data surveillance a reality with Tanya du Plessis

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Tanya Du Plessis, Chief Data Strategist and Solutions Officer at Bioforum. Together, they unpack what data surveillance really means and how to make it a practical reality in today’s clinical trials.

With over two decades of experience in clinical data management, Tanya shares how the evolving regulatory landscape – including ICH E8 and ICH E6(R3) – is pushing sponsors to adopt a more holistic, risk-based view of data. Rather than reacting to problems at the end of a study, she explains how data surveillance empowers teams to identify risks earlier, address root causes, and protect trial integrity.

Sylvain and Tanya discuss why regulators intentionally avoid a rigid definition of data surveillance, how cross-functional collaboration between statisticians, medics, and data managers is key, and why proactive strategies ultimately save both time and cost.

Tune in to explore how data surveillance is reshaping the role of data managers, the culture of oversight, and the future of trial success.

Watch the full webinar

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

Why clinical teams transition from legacy systems to CRScube

As the industry moves toward faster, more decentralized models, many teams find that the tools which once supported them now require significant manual workarounds to stay current.

From "Wow" to "How": What your questions taught us about the future of AI in clinical trials

While presenting our AI-led EDC setup functionality, we were impressed by the questions asked and what they reveal about our clients' readiness for AI-driven technology.

Beyond integration: How a unified eClinical platform transforms signal detection into site action

For Lead CRAs and CRAs, a unified eClinical platform can shorten the path from risk identification to site action, reducing the delays and inefficiencies caused by disconnected systems.